There’s a truth in health innovation: “Where data meets intent, change follows.” The latest Galen Growth report—FemTech 2.0: Doubling Down on Growth—is not just...
When GLP-1 medications like semaglutide began to gain attention, many people saw them as a breakthrough. For some people, these drugs help lower blood sugar,...
Dr Judy Mikovits scores 5 out of 5 on Medika's Quack Scale. She poses a high risk to the general public and we recommend against following any of her advice.